Tags: Four Stages Of Sleep EssayGcse Handling Data Maths CourseworkThe Importance Of Being Earnest Satire EssaysMean Median Mode Problem SolvingWhat Is Review Of LiteratureFood And Culture EssayArgumentative Essay Abortion Pro ChoiceCreative Writing Articles
Carlos Aquino, a 63 year old Filipino male with hormone-refractory prostate cancer is your clinic patient. Aquino was diagnosed with benign prostatic hypertrophy (BPH) several years ago and was taking alpha blockers for this condition.A year ago, his BPH symptoms worsened despite maximal therapy.
It is estimated that prostate cancer affected more than 241,000 new men in 2012, with 15% of these patients presenting with advanced disease.
In addition to radiotherapy Vic received an androgen deprivation (AD) drug called Lucrin in a clinical trial known as RADAR (Randomised Androgen Deprivation and Radiotherapy).
By inhibiting testosterone levels it shrinks the prostate and thus also shrinks the prostate cancer tissue.
Pivotal trial data were presented at the 2018 ASH Annual Meeting that demonstrated promising results for the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL). Esteva, MD, Ph D, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States.
In the ever-evolving treatment landscape in metastatic prostate cancer, healthcare providers have more options that ever before.